1. Home
  2. BSET vs PMN Comparison

BSET vs PMN Comparison

Compare BSET & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bassett Furniture Industries Incorporated

BSET

Bassett Furniture Industries Incorporated

N/A

Current Price

$18.76

Market Cap

169.9M

ML Signal

N/A

Logo ProMIS Neurosciences Inc. (ON)

PMN

ProMIS Neurosciences Inc. (ON)

N/A

Current Price

$14.82

Market Cap

131.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BSET
PMN
Founded
1902
2004
Country
United States
Canada
Employees
N/A
N/A
Industry
Home Furnishings
Pharmaceuticals and Biotechnology
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
169.9M
131.5M
IPO Year
1995
2022

Fundamental Metrics

Financial Performance
Metric
BSET
PMN
Price
$18.76
$14.82
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$42.67
AVG Volume (30 Days)
22.9K
102.6K
Earning Date
04-01-2026
05-13-2026
Dividend Yield
5.49%
N/A
EPS Growth
163.06
N/A
EPS
0.37
N/A
Revenue
$456,855,000.00
N/A
Revenue This Year
$1.72
N/A
Revenue Next Year
$3.78
N/A
P/E Ratio
$51.05
N/A
Revenue Growth
0.96
N/A
52 Week Low
$13.17
$0.29
52 Week High
$22.26
$27.40

Technical Indicators

Market Signals
Indicator
BSET
PMN
Relative Strength Index (RSI) 46.73 57.17
Support Level $18.78 $12.89
Resistance Level $20.81 $16.65
Average True Range (ATR) 0.58 0.89
MACD -0.13 -0.04
Stochastic Oscillator 23.27 63.14

Price Performance

Historical Comparison
BSET
PMN

About BSET Bassett Furniture Industries Incorporated

Bassett Furniture Industries Inc is a manufacturer, marketer, and retailer of home furnishings products in the United States. It operates through the following segments: The Wholesale segment focuses on the design, manufacture, sourcing, sale, and distribution of furniture products, the Retail segment which consists of company-owned stores, and the Corporate and others segment. Majority of revenue is from Wholesale sales of furniture and accessories.

About PMN ProMIS Neurosciences Inc. (ON)

ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimers disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins. Compnies product candidates are PMN310, PMN267, and PMN442. Lead product candidate is PMN310, a monoclonal antibody designed to treat AD by selectively targeting toxic, misfolded oligomers of amyloid-beta. PMN267 is companies second lead product candidate targeting ALS.

Share on Social Networks: